Search Results
Jun 10, 2026, 09:00 ET PHR DEADLINE: Levi & Korsinsky Reminds Phreesia, Inc. Investors of Upcoming Securities Class Action Deadline
receivables.At the same time, as alleged in the action, Phreesia promoted emerging products including MediFind, Phreesia OnCall, and its HCP marketing platform as additional catalysts. The Company claimed these initiatives would "enable us to sustain growth and enhance stakeholder value."
More news about: Levi & Korsinsky, LLP
Jun 10, 2026, 08:00 ET Allergan Aesthetics Releases 'The Aesthetics Evolution: What Consumers Really Want' Highlighting Consumer Motivations and Expectations in Aesthetics
patients of today and tomorrow. The report delivers insights from Allergan Aesthetics' consumer market research, healthcare provider (HCP) data and expert perspectives. Report insights were further validated through interviews with leading aesthetics practitioners from key U.S. markets,
More news about: AbbVie
Jun 09, 2026, 09:19 ET Doceree Launches Clinical Intent Signals, the Industry's First Real-Time Clinical Intent Layer for Omnichannel Healthcare Marketing
Redefining what is possible in HCP engagementClinical Intent Signals captures the digital exhaust of clinical decision-making — the searches, references, guideline lookups, peer content consumption, and workflow patterns that signal where an HCP is in their journey for a given
More news about: Doceree
Jun 09, 2026, 08:00 ET DeepIntent Launches Industry-First Tools for Healthcare Marketers to Target and Optimize Live Sports And Events With Precision
pharma KPIs from the start. We're now able to connect live event activation directly to the outcomes that matter to our clients: script lift, patient and HCP reach quality, and real-world behavior change. This is a shift the healthcare vertical has needed, and we're energized about the potential it offers."DeepIntent's
More news about: DeepIntent
Jun 08, 2026, 08:30 ET How To Strengthen Launch Strategies With Medical-Commercial Collaboration, Upcoming Webinar Hosted by Xtalks
and compliance teams elevate launches and improve patient outcomes. Attendees will learn how to use AI and data sharing to uncover trends, anticipate HCP needs, and create patient-centered messaging and strategies. The featured speakers will discuss how to enhance agility and spark innovation by outsourcing
More news about: Xtalks
Jun 02, 2026, 11:36 ET La nueva guía española adaptada culturalmente para el manejo de los síntomas del cáncer de mama metastásico se estrena en asco 2026
los síntomas del tratamiento del cáncer de mama metastásico (Guía MBC en español) disponible para los profesionales de la salud de Estados Unidos (HCP, por sus siglas en inglés) y que debutará en la Reunión Anual de 2026 de la Sociedad Estadounidense de Oncología Clínica (asco, por sus siglas en
More news about: Viver Health
Jun 02, 2026, 10:00 ET Health Union Opens Entries for the 2026 Social Health Awards
A new HCP-focused category and an expanded prize pack mark a bigger, bolder year for the premier awards program honoring Health LeadersPHILADELPHIA, June 2, 2026 /PRNewswire/ --
More news about: Health Union
Jun 02, 2026, 09:30 ET Lilly to spotlight growing hematology portfolio at 2026 European Hematology Association (EHA) Annual Meeting
Because severe renal impairment increases pirtobrutinib exposure, reduce Jaypirca dose in these patients according to approved labeling.PT HCP ISI MCL_CLL Q42025Please see
More news about: Eli Lilly and Company
Jun 02, 2026, 09:03 ET Mixed-Media Artist Eric Polins Seeks to Turn People's Artist Victory Into a $25,000 Gift for The Art of Elysium
voices, energy, and meaning alive for new audiences."While many know Polins professionally through his role as Managing Partner of Tampa-based HCP Associates, his artwork reveals a far more introspective side, blending themes of nostalgia, identity, lost Americana, music culture, memory, and the
More news about: Eric Polins
May 31, 2026, 08:01 ET Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer
with hepatic impairment.Retevmo (selpercatinib) is available as 40 mg and 80 mg capsules, and 40 mg, 80 mg, 120 mg, and 160 mg tablets.SE HCP ISI LA_NOV2025Please see full
More news about: Eli Lilly and Company
May 28, 2026, 07:05 ET Novel Spanish, Culturally Adapted Metastatic Breast Cancer Symptom Management Guide Debuts at ASCO 2026
https://www.viverguides.com/mbc-hcp-order-formAbout Viver HealthViver Health creates evidence-based educational resources that empower individuals to
More news about: Viver Health
May 26, 2026, 09:30 ET Doceree, Healthcare Marketing's AI-Powered Operating System, Earns Frost & Sullivan's 2026 Global Technology Innovation Leadership Recognition
journey from physician awareness to fill on a single platform. Its patented technology applies clinical, behavioural, and engagement signals to every HCP interaction in a privacy-compliant way. Founded in 2020, Doceree partners with the world's leading healthcare and life sciences brands to move physicians
More news about: Frost & Sullivan
May 26, 2026, 09:30 ET Doceree, Healthcare Marketing's AI-Powered Operating System, Earns Frost & Sullivan's 2026 Global Technology Innovation Leadership Recognition
journey from physician awareness to fill on a single platform. Its patented technology applies clinical, behavioural, and engagement signals to every HCP interaction in a privacy-compliant way. Founded in 2020, Doceree partners with the world's leading healthcare and life sciences brands to move physicians
More news about: Frost & Sullivan
May 22, 2026, 08:00 ET The Broken Command Center: New Doceree Survey Documents the Structural Cost of Pharma's Fragmented Marketing Stack
causeThe three patterns trace back to one structural gap: pharma brand teams have no unified command center. Brand health, competitive intelligence, HCP targeting, and performance measurement live in separate workflows, on separate systems, owned by separate teams.Every other strategically critical
More news about: Doceree
May 21, 2026, 17:00 ET Lilly to showcase oncology portfolio across tumor types and treatment modalities at the 2026 American Society of Clinical Oncology Annual Meeting
with hepatic impairment.Retevmo (selpercatinib) is available as 40 mg and 80 mg capsules, and 40 mg, 80 mg, 120 mg, and 160 mg tablets.SE HCP ISI LA_NOV2025Please see full
More news about: Eli Lilly and Company
May 20, 2026, 09:00 ET PHR DEADLINE: Levi & Korsinsky Reminds Phreesia, Inc. Investors of Upcoming Securities Class Action Deadline
receivables.At the same time, as alleged in the action, Phreesia promoted emerging products including MediFind, Phreesia OnCall, and its HCP marketing platform as additional catalysts. The Company claimed these initiatives would "enable us to sustain growth and enhance stakeholder value."
More news about: Levi & Korsinsky, LLP
May 19, 2026, 08:34 ET Helio Genomics Announces Strategic Commercial Partnership with Syneos Health® to Accelerate Nationwide Adoption of HelioLiver™, A Breakthrough AI-Powered Blood Test for Early Liver Cancer Detection
Bharat Tewarie, CEO of Helio Genomics. "Syneos Health's decades of experience successfully building and executing commercial programs will accelerate HCP engagement across the country. Together, we will expand access to this innovative test, empowering clinicians to detect liver cancer earlier and deliver
More news about: Helio Genomics
May 18, 2026, 11:00 ET Anthill Cloud - an AI-Powered Content Excellence Platform for the US Life Sciences Market
pharmaceutical, biotech, and MedTech commercial and medical teams. The platform integrates AI-powered content creation, modular authoring, and personalized HCP engagement into a single, compliance-ready ecosystem.
More news about: Anthill A/S
May 18, 2026, 05:07 ET Shaman Launches Shaman Atlas to Convert Pharma's Approved Content Into Structured Data
in the final format documents and impossible to extract. Until now.Shaman Atlas is purpose-built for pharma and the content types that drive HCP engagement: approved emails, landing pages, Detail Aids (CLM) and brochures. The product connects directly to Veeva Vault PromoMats and reads approved
More news about: Shaman
May 14, 2026, 16:01 ET Groundbreaking global survey captures the significant patient burden experienced with current standard-of-care bladder cancer treatments, underscoring urgency for continued innovation
and Mexico by The Harris Poll on behalf of Johnson & Johnson among 817 NMIBC patients (i.e., adults aged 18 or older who have been diagnosed by an HCP with bladder cancer, have specifically been diagnosed with NMIBC, and have a urologist who is primarily responsible for treating their bladder cancer)
More news about: Johnson & Johnson
May 14, 2026, 10:00 ET Supreme Group Launches Supreme Intelligence FDE+, the First Forward Deployed Expert Model Built for Healthcare and Life Sciences
experts have already built AI workflows for therapeutic-area intelligence, regulatory-compliant content generation, persona-driven campaign design, and HCP and patient engagement. They don't need to learn the industry. They've shaped it.Custom builds, not generic deployments. FDE+ engagements
More news about: Supreme Group
May 13, 2026, 08:00 ET BranchLab Raises $26M Series A Led by McKesson Ventures to Bring AI to Pharma Commercialization
activation, and optimization directly in the hands of pharma teams and their agencies—enabling them to act on high-intent patient and healthcare professional (HCP) audiences in near real time. Today, BranchLab is used by leading pharmaceutical companies and has delivered an average increase of nearly 70% in marketing
More news about: BranchLab Inc
May 12, 2026, 21:02 ET PharmaResearch Completes Five-Market Western Europe Roadshow for REJURAN
reflects the pre-existing global presence of REJURAN in the other markets, strength of our DOT™ technology, and the relevance of our product lineup for HCP. Based on the early response, we have raised our internal targets and will continue to expand distribution and education programs across Europe."
More news about: PharmaResearch Co., Ltd.
May 12, 2026, 09:00 ET ODAIA Marketing Intelligence Brings Real-Time, Individualized Campaign Orchestration to Pharma HCP Engagement
strategies.Score every HCP individually — instead of grouping HCPs by clusters or personas, evaluate each one against your objectives using real-time engagement, prescribing, and patient signals to pinpoint high-value prescription opportunities.Sequence individualized HCP journeys
More news about: ODAIA
May 12, 2026, 09:00 ET Inizio Launches Intelligent Congress to Turn Event Investment into Measurable Impact
This depth and breadth enable clients to move beyond fragmented, activity-based metrics and instead focus on what truly matters - meaningful shifts in HCP understanding, engagement, and behavior."Intelligent Congress ensures that scientific exchange and engagement is meaningful, measurable, and informative.
More news about: Inizio